MA46415A - Complexe et compositions pour le traitement de maladies ophtalmiques et dermatologiques - Google Patents
Complexe et compositions pour le traitement de maladies ophtalmiques et dermatologiquesInfo
- Publication number
- MA46415A MA46415A MA046415A MA46415A MA46415A MA 46415 A MA46415 A MA 46415A MA 046415 A MA046415 A MA 046415A MA 46415 A MA46415 A MA 46415A MA 46415 A MA46415 A MA 46415A
- Authority
- MA
- Morocco
- Prior art keywords
- complex
- treatment
- compositions
- ophthalmic
- dermatological diseases
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 241000238876 Acari Species 0.000 abstract 2
- 206010010741 Conjunctivitis Diseases 0.000 abstract 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 1
- WRYLYDPHFGVWKC-JTQLQIEISA-N (R)-(-)-p-Menth-1-en-4-ol Natural products CC(C)[C@@]1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-JTQLQIEISA-N 0.000 abstract 1
- WRYLYDPHFGVWKC-UHFFFAOYSA-N 4-terpineol Chemical compound CC(C)C1(O)CCC(C)=CC1 WRYLYDPHFGVWKC-UHFFFAOYSA-N 0.000 abstract 1
- 208000002874 Acne Vulgaris Diseases 0.000 abstract 1
- 206010061217 Infestation Diseases 0.000 abstract 1
- 206010072139 Ocular rosacea Diseases 0.000 abstract 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract 1
- 206010000496 acne Diseases 0.000 abstract 1
- 201000004484 acute conjunctivitis Diseases 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 208000010217 blepharitis Diseases 0.000 abstract 1
- 239000004202 carbamide Substances 0.000 abstract 1
- 201000005547 chronic conjunctivitis Diseases 0.000 abstract 1
- 229920002674 hyaluronan Polymers 0.000 abstract 1
- 229960003160 hyaluronic acid Drugs 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 201000007041 rosacea conjunctivitis Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La présente invention concerne un complexe de terpinène-4-ol et d'un polymère d'acide hyaluronique réticulé, en particulier avec de l'urée, et des compositions le contenant. L'invention concerne en outre l'utilisation du complexe, ou de compositions le contenant, dans l'hygiène de la zone périoculaire, et dans le traitement de la blépharite, de l'acné, de la rosacée, de la conjonctivite aiguë ou chronique, ou des infestations provoquées par les acariens, en particulier par les acariens demodexor et cheyletiella.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102016000096125A IT201600096125A1 (it) | 2016-09-26 | 2016-09-26 | Complesso e composizioni per il trattamento di affezioni oculari e cutanee |
| PCT/EP2017/074337 WO2018055194A1 (fr) | 2016-09-26 | 2017-09-26 | Complexe et compositions pour le traitement de maladies ophtalmiques et dermatologiques |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA46415A true MA46415A (fr) | 2019-07-31 |
| MA46415B1 MA46415B1 (fr) | 2021-02-26 |
Family
ID=57960613
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA46415A MA46415B1 (fr) | 2016-09-26 | 2017-09-26 | Complexe et compositions pour le traitement de maladies ophtalmiques et dermatologiques |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP3515409B1 (fr) |
| DK (1) | DK3515409T3 (fr) |
| ES (1) | ES2841940T3 (fr) |
| IT (1) | IT201600096125A1 (fr) |
| MA (1) | MA46415B1 (fr) |
| PL (1) | PL3515409T3 (fr) |
| SM (1) | SMT202100070T1 (fr) |
| WO (1) | WO2018055194A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112334167A (zh) * | 2018-06-15 | 2021-02-05 | 克罗马药品有限责任公司 | 包含交联聚合物的水凝胶组合物 |
| IT201800008192A1 (it) * | 2018-08-27 | 2020-02-27 | Ira St Ricerche Applicate Spa | Microsfere di acido ialuronico reticolato con urea e contenenti almeno un agente attivo o farmaco |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5583120A (en) * | 1993-08-04 | 1996-12-10 | Patent Biopharmaceutics, Inc. | Hyaluronic acid-urea pharmaceutical compositions and uses |
| ITMI20030195A1 (it) * | 2003-02-06 | 2004-08-07 | Bsd Bioscience Dev Snc Di O Mini C E Zucc | Formulazioni topiche contenenti principi attivi naturali adatte alla prevenzione e cura dei processi infiammatori delle mucose |
| US20090036554A1 (en) * | 2007-08-01 | 2009-02-05 | Burke Susan E | Ophthalmic compositions comprising a terpene compound |
| US8128968B2 (en) | 2007-08-29 | 2012-03-06 | Tissuetech, Inc. | Compositions and methods for treating Demodex infestations |
| ITMI20131193A1 (it) * | 2013-07-16 | 2015-01-17 | Ira Srl | Acido ialuronico reticolato, processo per la sua preparazione ed applicazioni in ambito estetico |
-
2016
- 2016-09-26 IT IT102016000096125A patent/IT201600096125A1/it unknown
-
2017
- 2017-09-26 MA MA46415A patent/MA46415B1/fr unknown
- 2017-09-26 EP EP17786829.6A patent/EP3515409B1/fr active Active
- 2017-09-26 PL PL17786829T patent/PL3515409T3/pl unknown
- 2017-09-26 DK DK17786829.6T patent/DK3515409T3/da active
- 2017-09-26 ES ES17786829T patent/ES2841940T3/es active Active
- 2017-09-26 WO PCT/EP2017/074337 patent/WO2018055194A1/fr not_active Ceased
- 2017-09-26 SM SM20210070T patent/SMT202100070T1/it unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2841940T3 (es) | 2021-07-12 |
| IT201600096125A1 (it) | 2018-03-26 |
| DK3515409T3 (da) | 2021-01-11 |
| SMT202100070T1 (it) | 2021-03-15 |
| EP3515409A1 (fr) | 2019-07-31 |
| PL3515409T3 (pl) | 2021-05-31 |
| WO2018055194A1 (fr) | 2018-03-29 |
| MA46415B1 (fr) | 2021-02-26 |
| EP3515409B1 (fr) | 2020-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202001057B (en) | Inhibiting ubiquitin specific peptidase 30 | |
| MA35365B1 (fr) | Pyrimidines annelées substituées et leur utilisation | |
| EP3351254A4 (fr) | Composition pour la prévention ou le traitement de maladies inflammatoires, contenant, en tant que principe actif, des cellules souches suexprimant sod3 | |
| TN2019000099A1 (fr) | Anticorps anti-lag-3 et compositions | |
| MA42376A (fr) | Dérivés d'oxopyridine substitués | |
| EA201791866A1 (ru) | Бициклические гетероциклы в качестве ингибиторов fgfr | |
| MA34248B1 (fr) | 5-fluoro-1h-pyrazolopyridines substituées et leur utilisation | |
| EA201390826A1 (ru) | ПИРИМИДИНОНОВЫЕ СОЕДИНЕНИЯ ДЛЯ ПРИМЕНЕНИЯ В ЛЕЧЕНИИ ЗАБОЛЕВАНИЙ ИЛИ СОСТОЯНИЙ, ОПОСРЕДОВАННЫХ Lp-PLA | |
| MA39033A1 (fr) | Formes solides d'acide {[5-(3-chlorophényl)-3-hydroxypyridine-2-carbonyl] amino}acétique, compositions et leurs utilisations | |
| MX2019015311A (es) | Composiciones de ésteres de ácido cannabidiólico y usos de las mismas. | |
| MA40283A (fr) | Aptamères spécifiques du récepteur tlr-4 et leurs utilisations | |
| MA41238B1 (fr) | Dérivés 5-[(pipérazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione en tant qu'inhibiteurs d'adamts pour le traitement de l'ostéoarthrit | |
| MA41977B1 (fr) | Imidazopyrazinones utilisées comme inhibiteurs de pde1 | |
| MA47356A1 (fr) | Dérivés d'isochromène utiles en tant qu'inhibiteurs des phosphoinositide 3-kinases | |
| EP2069377A4 (fr) | Procédés et compositions pour le traitement de maladies et de troubles de la peau | |
| BR112015017929A2 (pt) | di-hidropirimidinonas bicíclicas substituídas e seu uso como inibidores de atividade elastase neutrófila | |
| MA44948A1 (fr) | Inhibiteurs de bace 1 | |
| MA34545B1 (fr) | Co-cristaux et sels d'inhibiteurs de ccr3 | |
| EA202091446A1 (ru) | Способы лечения хронических воспалительных заболеваний | |
| EA201891608A1 (ru) | Производные 8-амино-2-оксо-1,3-диазаспиро[4,5]декана | |
| MX2016005940A (es) | Silicato de zirconio microporoso para el tratamiento de la hiperpotasemia. | |
| MA38925B1 (fr) | Dérivés de phénylalanine substitués | |
| EA201891610A1 (ru) | Производные 3-(карбоксиэтил)-8-амино-2-оксо-1,3-диазаспиро[4.5]декана | |
| MA35457B1 (fr) | Nouvelles formulations de pyriméthanil et leur utilisations dans le traitement des cultures | |
| WO2019016597A3 (fr) | Protéines synthétiques et leurs utilisations thérapeutiques |